scholarly article | Q13442814 |
P50 | author | Nancy J Cox | Q67954217 |
Eric R. Gamazon | Q37616152 | ||
Hae Kyung Im | Q47327124 | ||
P2093 | author name string | R Stephanie Huang | |
Dana Ziliak | |||
Bonnie LaCroix | |||
Danny S Park | |||
P2860 | cites work | DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines | Q21184030 |
Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma | Q21562611 | ||
Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS | Q21563317 | ||
Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis | Q82299247 | ||
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits | Q22066284 | ||
The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence bound transcripts independently of Argonaute proteins | Q24318187 | ||
miRBase: microRNA sequences, targets and gene nomenclature | Q24538656 | ||
A map of human genome variation from population-scale sequencing | Q24617794 | ||
New loci associated with kidney function and chronic kidney disease | Q24630646 | ||
A second generation human haplotype map of over 3.1 million SNPs | Q24651939 | ||
Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits | Q24675631 | ||
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance | Q24679991 | ||
Statistical significance for genomewide studies | Q24681264 | ||
Combinatorial microRNA target predictions | Q27860510 | ||
MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
The International HapMap Project | Q27860695 | ||
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists | Q28131785 | ||
CpG-rich islands and the function of DNA methylation | Q28131800 | ||
A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia | Q28211696 | ||
The let-7 microRNA represses cell proliferation pathways in human cells | Q28240833 | ||
Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2 | Q28254493 | ||
Posttranscriptional regulation of microRNA biogenesis in animals | Q28282519 | ||
Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery | Q28287147 | ||
Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer | Q28389041 | ||
Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines | Q28474104 | ||
Mixed effects modeling of proliferation rates in cell-based models: consequence for pharmacogenomics and cancer | Q28480587 | ||
Specificity of microRNA target selection in translational repression | Q28776123 | ||
Genomewide association study for onset age in Parkinson disease | Q29417034 | ||
Understanding mechanisms underlying human gene expression variation with RNA sequencing | Q29614412 | ||
Transcriptome genetics using second generation sequencing in a Caucasian population | Q29614413 | ||
Population genomics of human gene expression | Q29614905 | ||
Gene silencing by microRNAs: contributions of translational repression and mRNA decay | Q29615825 | ||
MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation | Q30426550 | ||
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study | Q30448742 | ||
A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. | Q30479559 | ||
miRNA malfunction causes spinal motor neuron disease | Q30495998 | ||
A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. | Q31034509 | ||
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts | Q33580704 | ||
Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates | Q33601105 | ||
SCAN: SNP and copy number annotation | Q33779644 | ||
The landscape of genetic complexity across 5,700 gene expression traits in yeast | Q33818641 | ||
The Influence of 3'UTRs on MicroRNA Function Inferred from Human SNP Data | Q34081307 | ||
Genetic loci influencing kidney function and chronic kidney disease | Q34109552 | ||
Downregulation of microRNA-200 in EBV-associated gastric carcinoma | Q34116271 | ||
Genetic variation in microRNA networks: the implications for cancer research | Q34177121 | ||
Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines | Q34288272 | ||
Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma | Q34657155 | ||
A comparison of background correction methods for two-colour microarrays | Q34667581 | ||
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. | Q34989475 | ||
Inferring causative variants in microRNA target sites | Q35198281 | ||
Population differences in microRNA expression and biological implications | Q35578546 | ||
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach | Q35946327 | ||
Evaluation of genetic variation contributing to differences in gene expression between populations | Q36718956 | ||
Genetic architecture of transcript-level variation in humans | Q37118371 | ||
Effect of population and gender on chemotherapeutic agent-induced cytotoxicity | Q37159518 | ||
The database of experimentally supported targets: a functional update of TarBase | Q37202497 | ||
Genetic variants contributing to daunorubicin-induced cytotoxicity | Q37271466 | ||
Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. | Q37344425 | ||
Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland | Q37354850 | ||
Discovery and genotyping of genome structural polymorphism by sequencing on a population scale | Q37390913 | ||
Small RNAs are on the move. | Q37791829 | ||
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. | Q38305314 | ||
MicroRNAs play an essential role in the development of cardiac hypertrophy | Q39340872 | ||
The effects of EBV transformation on gene expression levels and methylation profiles | Q39598932 | ||
Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b | Q39766210 | ||
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. | Q40168734 | ||
Modulation of cholinephosphotransferase activity in breast cancer cell lines by Ro5-4864, a peripheral benzodiazepine receptor agonist | Q40413401 | ||
KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling. | Q40447179 | ||
Mapping of the human genes (SLC23A2 and SLC23A1) coding for vitamin C transporters 1 and 2 (SVCT1 and SVCT2) to 5q23 and 20p12, respectively | Q43075692 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | transcriptome | Q252857 |
complex trait | Q55608248 | ||
microRNA expression | Q60681249 | ||
P304 | page(s) | 1046-1063 | |
P577 | publication date | 2012-05-31 | |
P1433 | published in | American Journal of Human Genetics | Q4744249 |
P1476 | title | Genetic architecture of microRNA expression: implications for the transcriptome and complex traits | |
P478 | volume | 90 |